甲状腺原发鳞状细胞癌诊治进展  

Progress in diagnosis and treatment of primary squamous cell carcinoma of thyroid

作　　者：张攀 李志辉[1] 魏涛[1] 朱精强[1] 雷建勇[1] ZHANG Pan;LI Zhihui;WEI Tao;ZHU Jingqiang;LEI Jianyong(Department of Thyroid&Parathyroid Surgery Center,West China Hospital,Sichuan University,Chengdu 610041,P.R.China)

机构地区：[1]四川大学华西医院甲状(旁)腺外科,成都610041

出　　处：《中国普外基础与临床杂志》2020年第12期1584-1586,共3页Chinese Journal of Bases and Clinics In General Surgery

基　　金：国家自然科学基金项目(项目编号:81702646)。

摘　　要：目的了解原发甲状腺鳞状细胞癌(primary squamous cell carcinoma of thyroid,PSCCT)的生物学行为,为其临床诊治提供参考。方法收集PSCCT的最新国内外报道进展,对其进行归纳分析。结果诊断PSCCT需要排除其他部位鳞癌转移到甲状腺的可能,其临床表现往往是声音嘶哑,局部梗阻症状,中位生存时间约12个月,治疗手段主要依靠手术完整切除。结论 PSCCT罕见,疾病进展快,总体预后差,治疗手段比较有限。Objective To understand the biological behavior of primary squamous cell carcinoma of thyroid(PSCCT), and provide references for its clinical diagnosis and treatment. Method The latest domestic and foreign reports of PSCCT were collected and analyzed. Results In the diagnosis of PSCCT, the possibility of metastasis of squamous cell carcinoma to thyroid should be excluded. It often presented with hoarseness, local obstruction, and the median survival time was about 12 months. The treatment mainly relies on complete surgical resection. Conclusion Primary squamous cell carcinoma of thyroid is a rare disease with rapid disease progression, poor overall prognosis and limited therapeutic options.

关 键 词：原发甲状腺鳞状细胞癌 手术切除 放疗 预后 

分 类 号：R736.1[医药卫生—肿瘤]